HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hossein Borghaei Selected Research
Hossein Borghaei Research Topics
Disease
51
Neoplasms (Cancer)
04/2024 - 01/2005
50
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 09/2008
20
Lung Neoplasms (Lung Cancer)
04/2024 - 09/2008
10
Disease Progression
11/2023 - 11/2004
6
Fatigue
02/2024 - 07/2013
6
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2006
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2013 - 01/2004
4
Neutropenia
11/2020 - 11/2004
4
Thrombocytopenia (Thrombopenia)
08/2017 - 01/2016
3
Melanoma (Melanoma, Malignant)
10/2019 - 10/2017
3
Nausea
01/2017 - 01/2004
2
Bites and Stings (Sting)
02/2024 - 01/2020
2
Diarrhea
02/2024 - 01/2018
2
Exanthema (Rash)
01/2022 - 11/2008
2
Malignant Mesothelioma
11/2021 - 11/2020
2
Anemia
11/2020 - 01/2018
2
Adenocarcinoma
01/2018 - 01/2016
2
Pneumonia (Pneumonitis)
01/2018 - 01/2017
2
Ovarian Neoplasms (Ovarian Cancer)
08/2017 - 06/2012
2
Body Weight (Weight, Body)
01/2017 - 10/2015
2
Castleman Disease (Castleman's Disease)
07/2013 - 08/2010
2
Breast Neoplasms (Breast Cancer)
06/2012 - 05/2007
2
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2010 - 01/2006
2
Carcinogenesis
02/2009 - 01/2006
2
Lymphoma (Lymphomas)
01/2006 - 10/2004
1
Aneuploidy (Aneuploid)
04/2024
1
Thymoma (Thymic Carcinoma)
02/2024
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023
1
Cardiomyopathies (Cardiomyopathy)
08/2023
1
Brain Neoplasms (Brain Tumor)
01/2023
1
Inflammation (Inflammations)
01/2022
1
Mesothelioma
11/2021
1
Lymphopenia (Lymphocytopenia)
11/2020
1
Turcot syndrome
10/2019
1
Urinary Bladder Neoplasms (Bladder Cancer)
10/2019
1
Circulating Neoplastic Cells
06/2019
Drug/Important Bio-Agent (IBA)
20
Nivolumab
IBA
02/2024 - 10/2015
14
Platinum
IBA
11/2021 - 09/2008
13
Immune Checkpoint Inhibitors
IBA
03/2024 - 01/2016
11
Biomarkers (Surrogate Marker)
IBA
03/2024 - 01/2016
10
Ipilimumab
IBA
01/2023 - 01/2017
9
B7-H1 Antigen
IBA
01/2023 - 05/2018
9
Docetaxel (Taxotere)
FDA Link
01/2021 - 09/2008
9
Monoclonal Antibodies
IBA
01/2016 - 10/2004
7
pembrolizumab
IBA
11/2020 - 11/2016
6
Tyrosine Kinase Inhibitors
IBA
02/2024 - 09/2009
5
ErbB Receptors (EGF Receptor)
IBA
04/2024 - 02/2009
5
Ligands
IBA
03/2024 - 10/2015
5
Pemetrexed (MTA)
FDA Link
11/2023 - 01/2016
4
Carboplatin (JM8)
FDA Link
Generic
11/2023 - 11/2008
4
Antibodies
IBA
06/2023 - 05/2007
4
Antigens
IBA
01/2020 - 09/2009
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2024 - 01/2014
3
atezolizumab
IBA
11/2023 - 05/2018
3
durvalumab
IBA
11/2021 - 05/2018
3
Paclitaxel (Taxol)
FDA Link
Generic
11/2008 - 11/2004
2
Programmed Cell Death 1 Receptor
IBA
03/2024 - 02/2024
2
DNA (Deoxyribonucleic Acid)
IBA
02/2024 - 10/2023
2
Interferon-gamma (Interferon, gamma)
IBA
02/2024 - 01/2023
2
Bevacizumab (Avastin)
FDA Link
11/2023 - 07/2019
2
Cell-Free Nucleic Acids
IBA
01/2022 - 06/2019
2
Proteins (Proteins, Gene)
FDA Link
11/2020 - 02/2018
2
RNA (Ribonucleic Acid)
IBA
08/2019 - 06/2019
2
Immunoconjugates (Immunoconjugate)
IBA
08/2017 - 01/2017
2
Lipase (Acid Lipase)
FDA Link
01/2017 - 01/2016
2
siltuximab
IBA
07/2013 - 08/2010
2
Cetuximab (Erbitux)
FDA Link
02/2009 - 11/2008
2
ibritumomab tiuxetan (Zevalin)
FDA Link
10/2004 - 01/2004
2
Yttrium
IBA
10/2004 - 01/2004
1
Aurora Kinase A
IBA
04/2024
1
MLN 8237
IBA
04/2024
1
vorolanib
IBA
02/2024
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2024
1
Glutamine (L-Glutamine)
FDA Link
02/2024
1
Platelet-Derived Growth Factor
IBA
02/2024
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
02/2024
1
Alanine Transaminase (SGPT)
IBA
02/2024
1
osimertinib
IBA
08/2023
1
Bispecific Antibodies
IBA
06/2023
1
pertuzumab
IBA
01/2023
1
AMG 757
IBA
01/2023
1
Trastuzumab (Herceptin)
FDA Link
01/2023
1
Hormones (Hormone)
IBA
01/2023
1
Genie
IBA
01/2023
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022
1
RNA-Binding Proteins (RNA-Binding Protein)
IBA
03/2021
1
sotorasib
IBA
01/2021
1
Surface Antigens (Surface Antigen)
IBA
01/2020
1
blinatumomab
IBA
01/2020
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
10/2019
1
AZD4547
IBA
10/2019
1
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
10/2019
1
Messenger RNA (mRNA)
IBA
06/2019
1
avelumab
IBA
05/2018
Therapy/Procedure
32
Therapeutics
03/2024 - 01/2004
27
Drug Therapy (Chemotherapy)
02/2024 - 01/2004
17
Immunotherapy
01/2024 - 12/2009
2
Radiotherapy
01/2020 - 12/2014
1
Time-to-Treatment
02/2024
1
Immunomodulation
05/2020